Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-10-22 01:26Core Viewpoint - The stock of Steady Medical (300888) has shown a decline in price and mixed capital flow trends, indicating potential volatility in investor sentiment and market performance [1][2][3]. Group 1: Stock Performance - As of October 21, 2025, Steady Medical's stock closed at 38.25 yuan, down 0.75% with a turnover rate of 0.77% and a trading volume of 44,600 shares, amounting to a total transaction value of 170 million yuan [1]. - Over the past five days, the stock has experienced a total decline of 3.14%, with the highest closing price at 39.32 yuan on October 16, 2025 [2]. Group 2: Capital Flow Analysis - On October 21, 2025, the net outflow of main funds was 896,300 yuan, accounting for 0.53% of the total transaction value, while retail investors saw a net inflow of 1,175,640 yuan, representing 6.91% of the total transaction value [1][2]. - The financing data indicates a net purchase of 4,518,200 yuan on October 21, 2025, with a total financing balance of 316 million yuan [3]. Group 3: Financial Metrics and Industry Comparison - Steady Medical's total market capitalization is 22.274 billion yuan, with a net asset value of 12.276 billion yuan, and a net profit of 492 million yuan, ranking 4th, 1st, and 3rd respectively in the beauty care industry [5]. - The company reported a gross margin of 48.33% and a net profit margin of 9.78%, both of which are above the industry averages [5]. - For the first half of 2025, the company achieved a main revenue of 5.296 billion yuan, a year-on-year increase of 31.31%, and a net profit of 492 million yuan, up 28.07% year-on-year [5]. Group 4: Institutional Ratings - In the last 90 days, 19 institutions have rated Steady Medical, with 16 buy ratings and 3 hold ratings, indicating a generally positive outlook [6]. - The average target price set by institutions over the past 90 days is 55.11 yuan, suggesting potential upside from the current trading price [6].